QL1101

bevacizumab biosimilar · Qilu Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for QL1101, covering 2017-06-22 to 2024-12-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Compare the Pharmacokinetics and Safety of QL1101 and EU-Avastin® in Healthy Volunteers [Phase 1]